Veeva Basics Adoption Accelerates Among Biotech Companies

More than 175 emerging biotechnology companies are adopting Veeva Basics to accelerate their drug development processes. Veeva Systems, headquartered in Pleasanton, California, announced on Tuesday that its pre-configured applications are helping these firms optimize their workflows.

This widespread adoption highlights a growing demand within the biotech sector for efficient, standardized tools that support early-stage research and development. Veeva Basics offers ready-to-use solutions that reduce the need for custom software development and speed up implementation, a critical factor in an industry where time is of the essence.

The platform's increasing use reflects a broader industry shift towards standardized and scalable technology solutions. Veeva Systems has focused on providing cloud-based solutions for life sciences companies, and this development strengthens its market position.

Companies are leveraging Veeva Basics' pre-configured applications to enhance areas such as clinical data management and regulatory compliance, allowing them to allocate resources more effectively towards core research and development activities.